Pharmaceutical

Johnson & Johnson gains FDA and EC approvals for TB treatment

Johnson & Johnson (J&J) has received the US FDA and EC approvals for SIRTURO (bedaquiline) to treat pulmonary tuberculosis (TB).

Jul 4, 2024 - 04:00
Johnson & Johnson gains FDA and EC approvals for TB treatment
Johnson & Johnson (J&J) has received the US FDA and EC approvals for SIRTURO (bedaquiline) to treat pulmonary tuberculosis (TB).
Read the original article

Tags:

Previous Article

Protecting your drug products: Strategies for preventing metal contamination in ...

Next Article

Moderna’s mRNA influenza vaccine receives $176m boost

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Aviceda, QUB to develop next-generation glyco-immune therapeutics

Aviceda, QUB to develop next-generation glyco-immune th...

Apr 10, 2023

Opinion: A judge’s infuriating ruling on vaccination puts Mississippi’s children at risk

Opinion: A judge’s infuriating ruling on vaccination pu...

Apr 27, 2023

STAT+: ‘Are we better off with the information?’: Experts spar over the benefits of liquid biopsy to catch cancer

STAT+: ‘Are we better off with the information?’: Exper...

May 7, 2023